Tumor Necrosis Factor-α-converting Enzyme (TACE/ADAM-17) Mediates the Ectodomain Cleavage of Intercellular Adhesion Molecule-1 (ICAM-1)*
暂无分享,去创建一个
U. Sen | W. English | G. Murphy | S. Sithu | N. Tsakadze | S. D’Souza | Utpal Sen | William R. English | Gillian Murphy | Stanley E. D'souza | Srinivas D. Sithu | Nina L. Tsakadze
[1] A. V. D. Stolpe,et al. Intercellular adhesion molecule-1 , 2020, Journal of Molecular Medicine.
[2] C. Blobel,et al. Evaluation of the Contribution of Different ADAMs to Tumor Necrosis Factor α (TNFα) Shedding and of the Function of the TNFα Ectodomain in Ensuring Selective Stimulated Shedding by the TNFα Convertase (TACE/ADAM17)* , 2004, Journal of Biological Chemistry.
[3] U. Sen,et al. Signals mediating cleavage of intercellular adhesion molecule-1. , 2004, American journal of physiology. Cell physiology.
[4] David C. Lee,et al. Selective roles for tumor necrosis factor alpha-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family: the juxtamembrane stalk determines cleavage efficiency. , 2004, The Journal of biological chemistry.
[5] C. Blobel,et al. Stimulated Shedding of Vascular Cell Adhesion Molecule 1 (VCAM-1) Is Mediated by Tumor Necrosis Factor-α-converting Enzyme (ADAM 17)* , 2003, Journal of Biological Chemistry.
[6] David C. Lee,et al. Substrate specificity and inducibility of TACE (tumour necrosis factor alpha-converting enzyme) revisited: the Ala-Val preference, and induced intrinsic activity. , 2003, Biochemical Society symposium.
[7] P. King,et al. ICAM‐1 isoforms: specific activity and sensitivity to cleavage by leukocyte elastase and cathepsin G , 2003, European journal of immunology.
[8] C. Mody,et al. Biologically active intercellular adhesion molecule-1 is shed as dimers by a regulated mechanism in the inflamed pleural space. , 2003, American journal of respiratory and critical care medicine.
[9] J. Arribas,et al. Protein ectodomain shedding. , 2002, Chemical reviews.
[10] Pedro Romero,et al. Matrix metalloproteinase 9 (MMP-9/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicity , 2002, Oncogene.
[11] M. Milla,et al. The tumor necrosis factor-alpha converting enzyme (TACE): a unique metalloproteinase with highly defined substrate selectivity. , 2002, Biochemistry.
[12] G. Folkers,et al. The production of macrophage inflammatory protein‐2 induced by soluble intercellular adhesion molecule‐1 in mouse astrocytes is mediated by src tyrosine kinases and p42/44 mitogen‐activated protein kinase , 2002, Journal of neurochemistry.
[13] E. Rovida,et al. Transmodulation of Cell Surface Regulatory Molecules via Ectodomain Shedding , 2002, Biological chemistry.
[14] J. Baselga,et al. Metalloprotease-dependent Protransforming Growth Factor-α Ectodomain Shedding in the Absence of Tumor Necrosis Factor-α-converting Enzyme* , 2001, The Journal of Biological Chemistry.
[15] H. Saya,et al. Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway , 2001, The Journal of cell biology.
[16] Li-chao Zhao,et al. Regulation of Membrane Metalloproteolytic Cleavage of L-selectin (CD62L) by the Epidermal Growth Factor Domain* , 2001, The Journal of Biological Chemistry.
[17] M. Eyries,et al. Increased Shedding of Angiotensin-converting Enzyme by a Mutation Identified in the Stalk Region* , 2001, The Journal of Biological Chemistry.
[18] V. Knäuper,et al. Localization of the Death Domain of Tissue Inhibitor of Metalloproteinase-3 to the N Terminus , 2000, The Journal of Biological Chemistry.
[19] B. Wolf,et al. Protein kinase C regulation of intracellular and cell surface amyloid precursor protein (APP) cleavage in CHO695 cells. , 2000, Biochemistry.
[20] E. Pluskota,et al. Src Homology Domain 2-containing Tyrosine Phosphatase 2 Associates with Intercellular Adhesion Molecule 1 to Regulate Cell Survival* , 2000, The Journal of Biological Chemistry.
[21] J. A. Conner,et al. Value of Serum-Soluble Intercellular Adhesion Molecule-1 for the Noninvasive Risk Assessment of Transplant Coronary Artery Disease, Posttransplant Ischemic Events, and Cardiac Graft Failure , 2000, Circulation.
[22] P. Slocombe,et al. Meltrin gamma(ADAM-9) mediates cellular adhesion through alpha(6)beta(1 )integrin, leading to a marked induction of fibroblast cell motility. , 2000, Journal of cell science.
[23] B. Fingleton,et al. Matrix metalloproteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc resorption. , 2000, The Journal of clinical investigation.
[24] C. Blobel,et al. Metalloprotease-disintegrins: modular proteins capable of promoting cell-cell interactions and triggering signals by protein-ectodomain shedding. , 1999, Journal of cell science.
[25] R. Black,et al. Unaltered Cleavage and Secretion of Angiotensin-converting Enzyme in Tumor Necrosis Factor-α-converting Enzyme-deficient Mice* , 1999, The Journal of Biological Chemistry.
[26] E. Kojro,et al. Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[27] E. Mekada,et al. A metalloprotease–disintegrin, MDC9/meltrin‐γ/ADAM9 and PKCδ are involved in TPA‐induced ectodomain shedding of membrane‐anchored heparin‐binding EGF‐like growth factor , 1998, The EMBO journal.
[28] A. Cantin,et al. Proteolytic cleavage of ICAM-1 by human neutrophil elastase. , 1998, Journal of immunology.
[29] Z. Werb,et al. A Cellular Striptease Act , 1998, Science.
[30] David C. Lee,et al. An essential role for ectodomain shedding in mammalian development. , 1998, Science.
[31] Joseph D. Buxbaum,et al. Evidence That Tumor Necrosis Factor α Converting Enzyme Is Involved in Regulated α-Secretase Cleavage of the Alzheimer Amyloid Protein Precursor* , 1998, The Journal of Biological Chemistry.
[32] R. Black,et al. ADAMs: focus on the protease domain. , 1998, Current opinion in cell biology.
[33] P. Slocombe,et al. TNF‐α converting enzyme (TACE) is inhibited by TIMP‐3 , 1998 .
[34] R. Huber,et al. Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[35] E. Wagner,et al. A strain‐independent postnatal neurodegeneration in mice lacking the EGF receptor , 1998, The EMBO journal.
[36] P. Ridker,et al. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men , 1998, The Lancet.
[37] J. Massagué,et al. Role of the Juxtamembrane Domains of the Transforming Growth Factor-α Precursor and the β-Amyloid Precursor Protein in Regulated Ectodomain Shedding* , 1997, The Journal of Biological Chemistry.
[38] E. Gardiner,et al. A Mitogenic Action for Fibrinogen Mediated through Intercellular Adhesion Molecule-1* , 1997, The Journal of Biological Chemistry.
[39] Nicole Nelson,et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells , 1997, Nature.
[40] N. Hooper,et al. Membrane protein secretases. , 1997, The Biochemical journal.
[41] S. Narula,et al. Purification of ADAM 10 from bovine spleen as a TNFα convertase , 1997 .
[42] J. Massagué,et al. Diverse Cell Surface Protein Ectodomains Are Shed by a System Sensitive to Metalloprotease Inhibitors (*) , 1996, The Journal of Biological Chemistry.
[43] T. Kishimoto,et al. Mutational analysis of the membrane-proximal cleavage site of L- selectin: relaxed sequence specificity surrounding the cleavage site , 1995, The Journal of experimental medicine.
[44] W. Brück,et al. Soluble forms of intercellular adhesion molecule-1 (ICAM-1) block lymphocyte attachment to cerebral endothelial cells , 1995, Journal of Neuroimmunology.
[45] S. Apte,et al. The Gene Structure of Tissue Inhibitor of Metalloproteinases (TIMP)-3 and Its Inhibitory Activities Define the Distinct TIMP Gene Family (*) , 1995, The Journal of Biological Chemistry.
[46] T. Carlos,et al. Leukocyte-endothelial adhesion molecules. , 1994, Blood.
[47] J. Flanagan,et al. Transmembrane kit ligand cleavage does not require a signal in the cytoplasmic domain and occurs at a site dependent on spacing from the membrane. , 1994, Molecular biology of the cell.
[48] T. Kishimoto,et al. Membrane proximal cleavage of L-selectin: identification of the cleavage site and a 6-kD transmembrane peptide fragment of L-selectin , 1994, The Journal of cell biology.
[49] Lei Wei,et al. Proteolytic release of human angiotensin-converting enzyme. Localization of the cleavage site. , 1993, The Journal of biological chemistry.
[50] P. Slocombe,et al. The activity of the tissue inhibitors of metalloproteinases is regulated by C-terminal domain interactions: a kinetic analysis of the inhibition of gelatinase A. , 1993, Biochemistry.
[51] R. Rothlein,et al. A form of circulating ICAM-1 in human serum. , 1991, Journal of immunology.
[52] Timothy A. Springer,et al. Adhesion receptors of the immune system , 1990, Nature.
[53] H. Schägger,et al. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. , 1987, Analytical biochemistry.
[54] K. Yeow,et al. Sorsby's fundus dystrophy tissue inhibitor of metalloproteinases-3 (TIMP-3) mutants have unimpaired matrix metalloproteinase inhibitory activities, but affect cell adhesion to the extracellular matrix. , 2002, Matrix biology : journal of the International Society for Matrix Biology.
[55] G Murphy,et al. Tissue inhibitors of matrix metalloendopeptidases. , 1995, Methods in enzymology.